Your browser doesn't support javascript.
loading
Standardising personalised diabetes care across European health settings: A person-centred outcome set agreed in a multinational Delphi study.
Porth, Ann-Kristin; Huberts, Anouk Sjoukje; Rogge, Alizé; Bénard, Angèle Helene Marie; Forbes, Angus; Strootker, Anja; Del Pozo, Carmen Hurtado; Kownatka, Dagmar; Hopkins, David; Nathanson, David; Aanstoot, Henk-Jan; Soderberg, Jeanette; Eeg-Olofsson, Katarina; Hamilton, Kathryn; Delbecque, Laure; Ninov, Lyudmil; Due-Christensen, Mette; Leutner, Michael; Simó, Rafael; Vikstrom-Greve, Sara; Rössner, Sophia; Flores, Vanesa; Seidler, Yuki; Hasler, Yvonne; Stamm, Tanja; Kautzky-Willer, Alexandra.
Afiliação
  • Porth AK; Department of Internal Medicine III, Divison of Endocrinology and Metabolism, Medical University Vienna, Vienna, Austria.
  • Huberts AS; Department of Quality and Patientcare, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Rogge A; Charité Center for Patient-Centered Outcomes Research, Department of Psychosomatic Medicine, Center for Internal Medicine and Dermatology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Bénard AHM; Vall d'Hebron Institute of Research (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Forbes A; Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, Kings College London, London, UK.
  • Strootker A; Medtronic International Trading Sàrl, Tolochenaz, Switzerland.
  • Del Pozo CH; JDRF International, New York, New York, USA.
  • Kownatka D; Roche Diabetes Care GmbH, Mannheim, Germany.
  • Hopkins D; Department of Diabetes, King's College London, London, UK.
  • Nathanson D; Institute for Diabetes, Endocrinology and Obesity, King's Health Partners, London, UK.
  • Aanstoot HJ; Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Huddinge, Sweden.
  • Soderberg J; Diabeter, Center for Focussed Diabetes Care and Research, Rotterdam, The Netherlands.
  • Eeg-Olofsson K; JDRF International, New York, New York, USA.
  • Hamilton K; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Göteborg, Sweden.
  • Delbecque L; National Diabetes Register, Göteborg, Sweden.
  • Ninov L; Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, Kings College London, London, UK.
  • Due-Christensen M; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Leutner M; European Patients' Forum (EPF), Brussels, Belgium.
  • Simó R; Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, Kings College London, London, UK.
  • Vikstrom-Greve S; Department of Internal Medicine III, Divison of Endocrinology and Metabolism, Medical University Vienna, Vienna, Austria.
  • Rössner S; Vall d'Hebron Institute of Research (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Flores V; Centro de Investigación Biomédica en Red Instituto de Salud Carlos III (CIBERDEM (ISCIII)), Madrid, Spain.
  • Seidler Y; Vall d'Hebron University Hospital, Barcelona, Spain.
  • Hasler Y; Autonomous University of Barcelona, Barcelona, Spain.
  • Stamm T; Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Huddinge, Sweden.
  • Kautzky-Willer A; Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Huddinge, Sweden.
Diabet Med ; 41(5): e15259, 2024 May.
Article em En | MEDLINE | ID: mdl-38017616
OBJECTIVE: Standardised person-reported outcomes (PRO) data can contextualise clinical outcomes enabling precision diabetes monitoring and care. Comprehensive outcome sets can guide this process, but their implementation in routine diabetes care has remained challenging and unsuccessful at international level. We aimed to address this by developing a person-centred outcome set for Type 1 and Type 2 diabetes, using a methodology with prospects for increased implementability and sustainability in international health settings. METHODS: We used a three-round questionnaire-based Delphi study to reach consensus on the outcome set. We invited key stakeholders from 19 countries via purposive snowball sampling, namely people with diabetes (N = 94), healthcare professionals (N = 65), industry (N = 22) and health authorities (N = 3), to vote on the relevance and measurement frequency of 64 previously identified clinical and person-reported outcomes. Subsequent consensus meetings concluded the study. RESULTS: The list of preliminary outcomes was shortlisted via the consensus process to 46 outcomes (27 clinical outcomes and 19 PROs). Two main collection times were recommended: (1) linked to a medical visit (e.g. diabetes-specific well-being, symptoms and psychological health) and (2) annually (e.g. clinical data, general well-being and diabetes self management-related outcomes). CONCLUSIONS: PROs are often considered in a non-standardised way in routine diabetes care. We propose a person-centred outcome set for diabetes, specifically considering psychosocial and behavioural aspects, which was agreed by four international key stakeholder groups. It guides standardised collection of meaningful outcomes at scale, supporting individual and population level healthcare decision making. It will be implemented and tested in Europe as part of the H2O project.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Limite: Humans Idioma: En Revista: Diabet Med Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Áustria

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Limite: Humans Idioma: En Revista: Diabet Med Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Áustria